Luke Chung is currently the VP of Clinical Development at Adagene Inc., where they lead an immuno-oncology program focusing on solid tumor indications. Previously, Luke held the position of Executive Medical Director and Global Projects Lead at Immune-Onc Therapeutics, overseeing preclinical and clinical development in immune therapy for oncology. They also served as Global Medical Director for Sanofi Genzyme, managing the medical and scientific aspects of treatments in neurology and oncology. Luke's extensive education includes an M.P.H. from Harvard University School of Public Health and a medical degree from Korea University.
This person is not in any teams
This person is not in any offices